A tale of two Paks

Biology of the Cell

Volumn 100, Issue 2, 2008, Pages 97-108

  Arias Romero, Luis E ^a   Chernoff, Jonathan ^a  

^a FOX CHASE CANCER CENTER   (United States)

Author keywords

Cancer; Inhibitor; p21 activated kinase (Pak); Signal transduction; Small GTPase

Indexed keywords

GUANOSINE TRIPHOSPHATASE; MITOGEN ACTIVATED PROTEIN KINASE; P21 ACTIVATED KINASE; P21 ACTIVATED KINASE 1; P21 ACTIVATED KINASE 2; P21 ACTIVATED KINASE 3; P21 ACTIVATED KINASE 4; P21 ACTIVATED KINASE 6; PROTEIN CDC42; RAC PROTEIN;

AMINO TERMINAL SEQUENCE; APOPTOSIS; BIOCHEMISTRY; CARBOXY TERMINAL SEQUENCE; CELL MOTILITY; CELL STRUCTURE; CELL SURVIVAL; CYTOSKELETON; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; ENZYME STRUCTURE; ENZYME SUBSTRATE; GENE DELETION; GENETIC TRANSCRIPTION; HUMAN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; TISSUE DISTRIBUTION; ANIMAL; CHEMISTRY; DRUG ANTAGONISM; ENZYME SPECIFICITY; ENZYMOLOGY; GENE EXPRESSION PROFILING; GENETICS; METABOLISM;

ANIMALS; CYTOSKELETON; GENE EXPRESSION PROFILING; HUMANS; MAP KINASE SIGNALING SYSTEM; P21-ACTIVATED KINASES; SUBSTRATE SPECIFICITY;

EID: 38949197214     PISSN: 02484900     EISSN: None     Source Type: Journal    
DOI: 10.1042/BC20070109     Document Type: Review

References (87)

1. Abo, A., Qu, J., Cammarano, M.S., Dan, C., Fritsch, A., Baud, V., Belisle, B. and Minden, A. (1998) PAK4, a novel effector for Cdc42Hs, is implicated in the reorganization of the actin cytoskeleton and in the formation of filopodia. EMBO J. 17, 6527-6540
2. Alahari, S.K. (2003) Nischarin inhibits Rac induced migration and invasion of epithelial cells by affecting signaling cascades involving PAK. Exp. Cell Res. 288, 415-424
3. Allen, K.M., Gleason, J.G., Bagrodia, S., Partington, M.W., MacMillan, J.C., Cerione, R.A., Mulley, J.C. and Walsh, C.A. (1998) PAK3 mutation in nonsyndromic X-linked mental retardation. Nat. Genet. 20, 25-30
4. Bagrodia, S., Taylor, S.J., Creasy, C.L., Chernoff, J. and Cerione, R.A. (1995) Identification of a mouse p21 (Cdc42/Rac) activated kinase. J. Biol. Chem. 270, 22731-22737
5. Beeser, A. and Chernoff, J. (2005) Production and use of a cell permeable inhibitor of group A Paks (TAT-PID) to analyze signal transduction. Methods 37, 203-207
6. Beeser, A., Jaffer, Z.M., Hofmann, C. and Chernoff, J. (2005) Role of group A p21-activated kinases in activation of extracellular-regulated kinase by growth factors. J. Biol. Chem. 280, 36609-36615
7. Benner, G.E., Dennis, P.B. and Masaracchia, R.A. (1995) Activation of an S6/H4 kinase (PAK 65) from human placenta by intramolecular and intermolecular autophosphorylation. J. Biol. Chem. 270, 21121-21128
8. Bienvenu, T., des Portes, V., McDonell, N., Carrie, A., Zemni, R., Couvert, P., Ropers, H.H., Moraine, C., van Bokhoven, H., Fryns, J.P., Allen, K., Walsh, C.A., Boue, J., Kahn, A., Chelly, J. and Beldjord, C. (2000) Missense mutation in PAK3, R67C, causes X-linked nonspecific mental retardation. Am. J. Med. Genet. 93, 294-298
9. Bokoch, G. M. (2003) Biology of the p21-activated kinases. Annu. Rev. Biochem. 72, 743-781
10. Bokoch, G.M., Wang, Y., Bohl, B.P., Sells, M.A., Quilliam, L.A. and Knaus, U.G. (1996) Interaction of the Nck adapter protein with p21-activated kinase (PAK1) J. Biol. Chem. 271, 25746-25749
11. Brown, J.L., Stowers, L., Baer, M., Trejo, J., Coughlin, S. and Chant, J. (1996) Human Ste20 homologue hPAK1 links GTPases to the JNK MAP kinase pathway. Curr. Biol. 6, 598-605
12. Callow, M.G., Clairvoyant, F., Zhu, S., Schryver, B., Whyte, D.B., Bischoff, J.R., Jallal, B. and Smeal, T. (2002) Requirement for PAK4 in the anchorage-independent growth of human cancer cell lines. J. Biol. Chem. 277, 550-558
13. ARF and mitogen-activated protein kinase signaling. Mol. Cell. Biol. 25, 9532-9542
14. C) associates with p21-activated kinase 1 and inhibits its activity during anoikis. J. Biol. Chem. 278, 20029-20036
15. Chong, C., Tan, L., Lim, L. and Manser, E. (2001) The mechanism of PAK activation. Autophosphorylation events in both regulatory and kinase domains control activity. J. Biol. Chem. 276, 17347-17353
16. Cotteret, S. and Chernoff, J. (2006) Nucleocytoplasmic shuttling of Pak5 regulates its antiapoptotic properties. Mol. Cell. Biol. 26, 3215-3230
17. Cotteret, S., Jaffer, Z.M., Beeser, A. and Chernoff, J. (2003) p21-activated kinase 5 (Pak5) localizes to mitochondria and inhibits apoptosis by phosphorylating BAD. Mol. Cell. Biol. 23, 5526-5539
18. Dan, C., Kelly, A., Bernard, O. and Minden, A. (2001) Cytoskeletal changes regulated by the PAK4 serine/threonine kinase are mediated by LIM kinase 1 and cofilin. J. Biol. Chem. 276, 32115-32121
19. Dan, C., Nath, N., Liberto, M. and Minden, A. (2002) PAK5, a new brain-specific kinase, promotes neurite outgrowth in N1E-115 cells. Mol. Cell. Biol. 22, 567-577
20. Daniels, R.H., Hall, P.S. and Bokoch, G.M. (1998) Membrane targeting of p21-activated kinase 1 (PAK1) induces neurite outgrowth from PC12 cells. EMBO J. 17, 754-764
21. Eblen, S.T., Slack, J.K., Weber, M.J. and Catling, A.D. (2002) Rac-PAK signaling stimulates extracellular signal-regulated kinase (ERK) activation by regulating formation of MEKI-ERK complexes. Mol. Cell. Biol. 22, 6023-6033
22. Eswaran, J., Lee, W.H., Debreczeni, J.E., Filippakopoulos, P., Turnbull, A., Fedorov, O., Deacon, S.W., Peterson, J.R. and Knapp, S. (2007) Crystal Structures of the p21-activated kinases PAK4, PAK5, and PAK6 reveal catalytic domain plasticity of active group II PAKs. Structure 15, 201-213
23. Etienne-Manneville, S. and Hall, A. (2002) Rho GTPases in cell biology. Nature 420, 629-635
24. Gatti, A., Huang, Z., Tuazon, P.T. and Traugh, J.A. (1999) Multisite autophosphorylation of p21-activated protein kinase α-PAK as a function of activation. J. Biol. Chem. 274, 8022-8028
25. Gedeon, A.K., Nelson, J., Gecz, J. and Mulley, J.C. (2003) X-linked mild non-syndromic mental retardation with neuropsychiatric problems and the missense mutation A365E in PAK3. Am. J. Med. Genet. A. 120, 509-517
26. Gnesutta, N. and Minden, A. (2003) Death receptor-induced activation of initiator caspase 8 is antagonized by serine/threonine kinase PAK4. Mol. Cell. Biol. 23, 7838-7848
27. Gnesutta, N., Qu, J. and Minden, A. (2001) The serine/threonine kinase PAK4 prevents caspase activation and protects cells from apoptosis. J. Biol. Chem. 276, 14414-14419
28. Greenman, C., Stephens, R, Smith, R., Dalgliesh, G.L., Hunter, C., Bignell, G., Davies, H., Teague, J., Butler, A., Stevens, C. et al. (2007) Patterns of somatic mutation in human cancer genomes. Nature 446, 153-158
29. Guo, D., Tan, Y.C., Wang, D., Madhusoodanan, K.S., Zheng, Y., Maack, T., Zhang, J.J. and Huang, X.Y. (2007) A Rac-cGMP signaling pathway. Cell 128, 341-355
30. Hofmann, C., Shepelev, M. and Chernoff, J. (2004) The genetics of Pak. J. Cell Sci. 117, 4343-4354
31. Holm, C., Rayala, S., Jirstrom, K., Stal, O., Kumar, R. and Landberg, G. (2006) Association between Pak1 expression and subcellular localization and tamoxifen resistance in breast cancer patients. J. Natl. Cancer Inst. 98, 671-680
32. Howe, A.K. and Juliano, R.L. (2000) Regulation of anchorage-dependent signal transduction by protein kinase A and p21-activated kinase. Nat. Cell Biol. 2, 593-600
33. Jaffer, Z.M. and Chernoff, J. (2002) p21-activated kinases: three more join the Pak. Int. J. Biochem. Cell Biol. 34, 713-717
34. Kaur, R., Liu, X., Gjoerup, O., Zhang, A.H., Yuan, X., Balk, S.P., Schneider, M.C. and Lu, M.L. (2005) Activation of p21-activated kinase 6 by MAP kinase kinase 6 and p38 MAP kinase. J. Biol. Chem. 280, 3323-3330
35. King, C.C., Gardiner, E.M., Zenke, F.T., Bohl, B.P., Newton, A.C., Hemmings, B.A. and Bokoch, G.M. (2000) p21-activated kinase (PAK1) is phosphorylated and activated by 3-phosphoinositide-dependent kinase-1 (PDK1) J. Biol. Chem. 275, 41201-41209
36. Kiosses, W.B., Hood, J., Yang, S., Gerritsen, M.E., Cheresh, D.A., Alderson, N. and Schwartz, M.A. (2002) A dominant-negative p65 PAK peptide inhibits angiogenesis. Circ. Res. 90, 697-702
37. Kissil, J.L., Wilker, E.W., Johnson, K.C., Eckman, M.S., Yaffe, M.B. and Jacks, T (2003) Merlin, the product of the Nf2 tumor suppressor gene, the p21-activated is an inhibitor of kinase, Pak1. Mol. Cell 12, 841-849
38. Koh, C.G., Tan, E.J., Manser, E. and Lim, L. (2002) The p21-activated kinase PAK is negatively regulated by POPX1 and POPX2, a pair of serine/ threonine phosphatases of the PP2C family. Curr. Biol. 12, 317-321
39. Lee, S.R., Ramos, S.M., Ko, A., Masiello, D., Swanson, K.D., Lu, M.L. and Balk, S.P. (2002) AR and ER interaction with a p21-activated kinase (PAK6) Mol. Endocrinol. 16, 85-99
40. Leeuw, T., Wu, C., Schrag, J.D., Whiteway, M., Thomas, D.Y. and Leberer, E. (1998) Interaction of a G-protein β-subunit with a conserved sequence in Ste20/PAK family protein kinases. Nature 391, 191-195
41. Lei, M., Lu, W., Meng, W., Parrini, M.C., Eck, M.J., Mayer, B.J. and Harrison, S.C. (2000) Structure of PAK1 in an autoinhibited conformation reveals a multistage activation switch. Cell 102, 387-397
42. Li, X.F. and Minden, A. (2003) Targeted disruption of the gene for the PAK5 kinase in mice. Mol. Cell. Biol. 23, 7134-7142
43. Loo, T.H., Ng, Y.W., Lim, L. and Manser, E. (2004) GIT1 activates p2l-activated kinase through a mechanism independent of p2l binding. Mol. Cell. Biol. 24, 3849-3859
44. Lu, W., Katz, S., Gupta, R. and Mayer, B.J. (1997) Activation of Pak by membrane localization mediated by an SH3 domain from the adaptor protein Nck. Curr. Biol. 7, 85-94
45. Lucas, K.A., Pitari, G.M., Kazerounian, S., Ruiz-Stewart, I., Park J., Schulz, S., Chepenik, K.P. and Waldman, S.A. (2000) Guanylyl cyclases and signaling by cyclic GMP. Pharmacol. Rev. 52, 375-413
46. Manser, E., Leung, T., Salihuddin, H., Zhao, Z.S. and Lim, L. (1994) A brain serine threonine protein-kinase activated by Cdc42 and Rac1. Nature 367, 40-46
47. Manser, E., Huang, H.Y., Loo, T.H., Chen, X.Q., Dong, J.M., Leung, T. and Lim, L. (1997) Expression of constitutively active αc-PAK reveals effects of the kinase on actin and focal complexes. Mol. Cell. Biol. 17, 1129-1143
48. Manser, E., Loo, T.H., Koh, C.G., Zhao, Z.S., Chen, X.Q., Tan, L., Tan, I., Leung, T. and Lim, L. (1998) PAK kinases are directly coupled to the PIX family of nucleotide exchange factors. Mol. Cell 1, 183-192
49. Meng, J., Meng, Y., Hanna, A., Janus, C. and Jia, Z. (2005) Abnormal long-lasting synaptic plasticity and cognition in mice lacking the mental retardation gene Pak3. J. Neurosci. 25, 6641-6650
50. Morreale, A., Venkatesan, M., Mott, H.R., Owen, D., Nietlispach, D., Lowe, P.N. and Laue, E.D. (2000) Structure of Cdc42 bound to the GTPase binding domain of PAK. Nat. Struct. Biol. 7, 384-388
51. Nheu, T.V., He, H., Hirokawa, Y., Tamaki, K., Florin, L., Schmitz, M.L., Suzuki-Takahashi, I., Jorissen, R.N., Burgess, A.W., Nishimura, S., Wood, J. and Maruta, H. (2002) The K252a derivatives, inhibitors for the PAK/MLK kinase family selectively block the growth of RAS transformants. Cancer J. 8, 328-336
52. Nheu, T., He, H., Hirokawa, Y., Walker, F., Wood, J. and Maruta, H. (2004) PAK is essential for RAS-induced upregulation of cyclin D1 during the G1 to S transition. Cell Cycle 3, 71-74
53. Pandey, A., Dan, I., Kristiansen, T.Z., Watanabe, N.M., Voldby, J., Kajikawa, E., Khosravi-Far, R., Blagoev, B. and Mann, M. (2002) Cloning and characterization of PAK5, a novel member of mammalian p2l-activated kinase-II subfamily that is predominantly expressed in brain. Oncogene 21, 3939-3948
54. Peippo, M., Koivisto, A.M., Sarkamo, T., Sipponen, M., von Koskull, H., Ylisaukko-Oja, T., Rehnstrom, K., Froyen, G., Ignatius, J. and Jarvela, I. (2007) PAK3 related mental disability: further characterization of the phenotype. Am. J. Med. Genet. A. 143, 2406-2416
55. Porchia, L.M., Guerra, M., Wang, Y.C., Zhang, Y., Espinosa, A.V., Shinohara, M., Kulp, S.K., Kirschner, L.S., Saji, M., Chen, C.S. and Ringel, M.D. (2007) 2-amino-N-{4-[5-(2-phenanthrenyl)-3- (trifluoromethyl)-lH-pyrazol-1-yl]-phenyl} acetamide (OSU-03012), a celecoxib derivative, directly targets p2l-activated kinase. Mol. Pharmacol. 72, 1124-1131
56. Puto, L.A., Pestonjamasp, K., King, C.C. and Bokoch, G.M. (2003) p2l-activated kinase 1 (PAK1) interacts with the Grb2 adapter protein to couple to growth factor signaling. J. Biol. Chem. 278, 9388-9393
57. Qu, J., Cammarano, M.S., Shi, Q., Ha, K.C., de Lanerolle, P. and Minden, A. (2001) Activated PAK4 regulates cell adhesion and anchorage-independent growth. Mol. Cell. Biol. 21, 3523-3533
58. Qu, J., Li, X.F., Novitch, B.G., Zheng, Y., Kohn, M., Xie, J.M., Kozinn, S., Bronson, R., Beg, A.A. and Minden, A. (2003) PAK4 kinase is essential for embryonic viability and for proper neuronal development. Mol. Cell. Biol. 23, 7122-7133
59. Rayala, S.K., Talukder, A.H., Balasenthil, S., Tharakan, R., Barnes, C.J., Wang, R.A., Aldaz, M., Khan, S. and Kumar, R. (2006) P21-activated kinase 1 regulation of estrogen receptor-α activation involves serine 305 activation linked with serine 118 phosphorylation. Cancer Res. 66, 1694-1701
60. Rennefahrt, U.E., Deacon, S., Parker, S.A., Devarajan, K., Beeser, A., Chernoff, J., Knapp, S., Turk, B.E. and Peterson, J.R. (2007) Specificity profiling of Pak kinases allows identification of novel phosphorylation sites. J. Biol. Chem. 282, 15667-15678
61. Rife, M., Mallolas, J., Castellvi-Bel, S., Badenas, C., Jimenez, D. and Mila, M. (2000) Molecular study of the PAK3 and GDI1 genes in nonsyndromic X-linked mental retardation spanish patients. Am. J. Med. Genet. 94, 389-391
62. Roux, P.P., Dorval, G., Boudreau, M., Angers-Loustau, A., Morris, S.J., Makkerh, J. and Barker, P.A. (2002) K252a and CEP1347 are neuroprotective compounds that inhibit mixed-lineage kinase-3 and induce activation of Akt and ERK. J. Biol. Chem. 277, 49473-49480
63. Schrantz, N.M., Sun, Z. and Bokoch, G.M. (2002) Repression of AR-mediated transcription by PAK6 is dependant on PAK6 kinase activity. Mol. Biol. Cell. 13, 154a
64. Schrantz, N., da Silva Correia, J., Fowler, B., Ge, Q., Sun, Z. and Bokoch, G.M. (2004) Mechanism of p21-activated kinase 6-mediated inhibition of androgen receptor signaling. J. Biol. Chem. 279, 1922-1931
65. Sells, M.A., Knaus, U.G., Bagrodia, S., Ambrose, D.M., Bokoch, G.M. and Chernoff, J. (1997) Human p21-activated kinase (Pak1) regulates actin organization in mammalian cells. Curr. Biol. 7, 202-210
66. Sells, M.A., Boyd, J.T. and Chernoff, J. (1999) p21-activated kinase 1 (Pak1) regulates cell motility in mammalian fibroblasts. J. Cell Biol. 145, 837-849
67. Slack-Davis, J.K., Eblen, S.T., Zecevic, M., Boerner, S.A., Tarcsafalvi, A., Diaz, H.B., Marshall, M.S., Weber, M.J., Parsons, J.T. and Catling, A.D. (2003) PAKI phosphorylation of MEK1 regulates fibronectin-stimulated MAPK activation. J. Cell Blol. 162, 281-291
68. Stockton, R., Reutershan, J., Scott, D., Sanders, J., Ley, K. and Schwartz, M.A. (2007) Induction of vascular permeability: β PIX and GIT1 scaffold the activation of extracellular signal-regulated kinase by PAK. Mol. Biol. Cell. 18, 2346-2355
69. 212 phosphorylation. J. Biol. Chem. 280, 2055-2064
70. Talukder, A.H., Meng, Q. and Kumar, R. (2006) CRIPak, a novel endogenous Pak1 inhibitor. Oncogene 25, 1311-1319
71. Tang, Y., Zhou, H., Chen, A., Pittman, R.N. and Field, J. (2000) The Akt proto-oncogene links Ras to Pak and cell survival signals. J. Biol. Chem. 275, 9106-9109
72. ten Klooster, J.P., Jaffer, Z.M., Chernoff, J. and Hordijk, P.L. (2006) Targeting and activation of Rac1 are mediated by the exchange factor β-Pix. J. Cell Biol. 172, 759-769
73. rac1-activated serine/ threonine kinase that is rapidly activated by thrombin in platelets. J. Biol. Chem. 270, 26690-26697
74. 5α. GTPγS. Science 278, 1907-1916
75. Thompson, G., Owen, D., Chalk, P.A. and Lowe, P.N. (1998) Delineation of the Cdc42/Rac-binding domain of p21-activated kinase. Biochemistry 37, 7885-7891
76. Thullberg, M., Gad, A., Beeser, A., Chernoff, J. and Stromblad, S. (2007) The kinase-inhibitory domain of p21-activated kinase 1 (PAK1) inhibits cell cycle progression independent of PAK1 kinase activity. Oncogene 26, 1820-1828
77. Tsakiridis, T., Taha, C., Grinstein, S. and Klip, A. (1996) Insulin activates a p21-activated kinase in muscle cells via phosphatidylinositol 3-kinase. J. Biol. Chem. 271, 19664-19667
78. van de Wijngaart, D.J., van Royen, M.E., Hersmus, R., Pike, A.C., Houtsmuller, A.B., Jenster, G., Trapman, J. and Dubbink, H.J. (2006) Novel FXXFF and FXXMF motifs in androgen receptor cofactors mediate high affinity and specific interactions with the ligand-binding domain. J. Biol. Chem. 281, 19407-19416
79. Wang, R.A., Mazumdar, A., Vadlamudi, R.K. and Kumar, R. (2002) P21-activated kinase-1 phosphorylates and transactivates estrogen receptor-α and promotes hyperplasia in mammary epithelium. EMBO J. 21, 5437-5447
80. Wang, R.A., Zhang, H., Balasenthil, S., Medina, D. and Kumar, R. (2006) PAK1 hyperactivation is sufficient for mammary gland tumor formation. Oncogene 25, 2931-2936
81. Westphal, R.S., Coffee, R.L., Marotta, A., Pelech, S.L. and Wadzinski, B.E. (1999) Identification of kinase-phosphatase signaling modules composed of p70 S6 kinase-protein phosphatase 2A (PP2A) and p21-activated kinase-PP2A. J. Biol. Chem. 274, 687-692
82. Wu, X. and Frost, J.A. (2006) Multiple Rho proteins regulate the subcellular targeting of PAK5. Biochem. Biophys. Res. Commun. 351, 328-335
83. Xia, C.Z., Ma, W.B., Stafford, L.J., Marcus, S., Xiong, W.C. and Liu, M.Y. (2001) Regulation of the p21-activated kinase (PAK) by a human Gβ-like WD-repeat protein, hPlP1. Proc. Natl. Acad. Sci. U.S.A. 98, 6174-6179
84. Yang, F, Li, X., Sharma, M., Zarnegar, M., Lim, B. and Sun, Z. (2001) Androgen receptor specifically interacts with a novel p21-activated kinase, PAK6. J. Biol. Chem. 276, 15345-15353
85. Zhan, Q., Ge, Q., Ohira, T., Van Dyke, T. and Badwey, J.A. (2003) p21-activated kinase 2 in neutrophils can be regulated by phosphorylation at multiple sites and by a variety of protein phosphatases. J. Immunol. 171, 3785-3793
86. Zhao, Z.S., Manser, E., Chen, X.Q., Chong, C., Leung, T. and Lim, L. (1998) A conserved negative regulatory region in αPAK: inhibition of PAK kinases reveals their morphological roles downstream of Cdc42 and Rac1. Mol. Cell. Biol. 18, 2153-2163
87. Zhao, L., Ma, Q.L., Calon, F., Harris-White, M.E., Yang, F., Lim, G.P., Morihara, T., Ubeda, O.J., Ambegaokar, S., Hansen, J.E., Weisbart, R.H., Teter, B., Frautschy, S.A. and Cole, G.M. (2006) Role of p21-activated kinase pathway defects in the cognitive deficits of Alzheimer disease. Nat. Neurosci. 9, 234-242